Cancer Hair Loss Bill Stalled Over Cost Concerns

A legislative effort in Rhode Island to mandate insurance coverage for scalp cooling treatments, aimed at preventing chemotherapy-induced hair loss, has been stalled. The bill, which had previously passed the Senate, faced concerns from the House Human Services Committee regarding potential increases in health insurance premiums for the state and businesses. Supporters of the bill, including cancer survivors, highlighted the significant psychological distress caused by hair loss during treatment. They argued that the cost of the treatment, estimated between $1,800 to $2,500, and the technology required are manageable, with one study suggesting a negligible impact on premiums.

Representative Susan R. Donovan, chairwoman of the committee, acknowledged the bill's merit but expressed apprehension about its financial implications. Similarly, Representative Karen Alzate, the bill's sponsor, noted the pushback on costs, though she believed them to be minimal. Despite not passing this session, advocates like Christine Imbriglio, who leads a support group for scalp cooling, expressed optimism about future progress. They plan to make the bill a priority again in the next legislative session, building on the momentum and conversations initiated this year.